Challenging a dogma: five-year survival does not equal cure in all colorectal cancer patients.

about

Challenging a dogma: five-year survival does not equal cure in all colorectal cancer patients.

Item

http://www.wikidata.org/entity/Q46627034

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Challenging a dogma: five-year ...... ll colorectal cancer patients.

@en

Challenging a dogma: five-year ...... ll colorectal cancer patients.

@nl

type

Item

label

Challenging a dogma: five-year ...... ll colorectal cancer patients.

@en

Challenging a dogma: five-year ...... ll colorectal cancer patients.

@nl

prefLabel

Challenging a dogma: five-year ...... ll colorectal cancer patients.

@en

Challenging a dogma: five-year ...... ll colorectal cancer patients.

@nl

P1476

Challenging a dogma: five-year ...... ll colorectal cancer patients.

@en

P2093

Omar Abdel-Rahman

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies

The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 mont

Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging.

Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: are all mutations equal?

Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study.

Functional consequences of colorectal cancer management.

Advances in the management of colorectal cancer: from biology to treatment.

Clinical follow-up does not improve survival after resection of stage I-III colorectal cancer: A cohort study.

Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial.

P304

187-192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14737140.2018.1409625

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Omar Abdel-Rahman

P577

2017-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29168934

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer